|
EP1012180B1
(en)
|
1997-08-11 |
2004-12-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor peptide analogues
|
|
ES2241157T3
(es)
|
1997-08-11 |
2005-10-16 |
Boehringer Ingelheim (Canada) Ltd. |
Peptidos inhibidores de la hepatitis c.
|
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
|
AR022061A1
(es)
|
1998-08-10 |
2002-09-04 |
Boehringer Ingelheim Ca Ltd |
Peptidos inhibidores de la hepatitis c, una composicion farmaceutica que los contiene, el uso de los mismos para preparar una composicion farmaceutica, el uso de un producto intermedio para la preparacion de estos peptidos y un procedimiento para la preparacion de un peptido analogo de los mismos.
|
|
UA74546C2
(en)
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
|
EP1162196A4
(en)
|
1999-12-27 |
2003-04-16 |
Japan Tobacco Inc |
COMPOUNDS WITH JOINED CYCLES AND THEIR USE AS MEDICAMENTS
|
|
ES2317900T3
(es)
|
2000-04-05 |
2009-05-01 |
Schering Corporation |
Inhibidores de serina proteasa ns3 macrociclicos del virus de la hepatitis c que comprenden fragmentos n-ciclicas p2.
|
|
AU2001253621A1
(en)
|
2000-04-19 |
2001-11-07 |
Schering Corporation |
Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
|
|
US6448281B1
(en)
|
2000-07-06 |
2002-09-10 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
CN1498224A
(zh)
|
2000-07-21 |
2004-05-19 |
���鹫˾ |
用作丙型肝炎病毒ns3-丝氨酸蛋白酶抑制剂的新型肽
|
|
SK742003A3
(en)
|
2000-07-21 |
2003-06-03 |
Schering Corp |
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
|
|
AR034127A1
(es)
|
2000-07-21 |
2004-02-04 |
Schering Corp |
Imidazolidinonas como inhibidores de ns3-serina proteasa del virus de hepatitis c, composicion farmaceutica, un metodo para su preparacion, y el uso de las mismas para la manufactura de un medicamento
|
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
|
ES2263687T3
(es)
|
2000-11-20 |
2006-12-16 |
Bristol-Myers Squibb Company |
Inhibidores tripeptidicos de la hepatitis c.
|
|
AU3659102A
(en)
|
2000-12-12 |
2002-06-24 |
Schering Corp |
Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
|
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
WO2003005025A1
(en)
*
|
2001-07-03 |
2003-01-16 |
Biovitrum Ab |
Methods for identifying compounds modulating the activity of ppar-gamma
|
|
CA2448737C
(en)
|
2001-07-20 |
2010-06-01 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
WO2003026587A2
(en)
|
2001-09-26 |
2003-04-03 |
Bristol-Myers Squibb Company |
Compounds useful for treating hepatitus c virus
|
|
US6867185B2
(en)
|
2001-12-20 |
2005-03-15 |
Bristol-Myers Squibb Company |
Inhibitors of hepatitis C virus
|
|
CN100352819C
(zh)
|
2002-01-23 |
2007-12-05 |
先灵公司 |
作为ns3－丝氨酸蛋白酶抑制剂的脯氨酸化合物用于制备治疗丙型肝炎病毒感染的药物
|
|
CA2369711A1
(en)
|
2002-01-30 |
2003-07-30 |
Boehringer Ingelheim (Canada) Ltd. |
Macrocyclic peptides active against the hepatitis c virus
|
|
CA2369970A1
(en)
|
2002-02-01 |
2003-08-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor tri-peptides
|
|
CA2370396A1
(en)
|
2002-02-01 |
2003-08-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor tri-peptides
|
|
GB0209884D0
(en)
|
2002-04-30 |
2002-06-05 |
Ares Trading Sa |
Proteins
|
|
DE60324552D1
(en)
|
2002-05-20 |
2008-12-18 |
Bristol Myers Squibb Co |
Substituierte cycloalkyl p1' hepatitis c virus inhibitoren
|
|
ES2361011T3
(es)
|
2002-05-20 |
2011-06-13 |
Bristol-Myers Squibb Company |
Inhibidores del virus de la hepatitis c.
|
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
|
US7196111B2
(en)
|
2002-06-04 |
2007-03-27 |
Schering Corporation |
Pyrazolo[1,5a]pyrimidine compounds as antiviral agents
|
|
US20040138109A1
(en)
|
2002-09-30 |
2004-07-15 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Potent inhibitor of HCV serine protease
|
|
US20050075279A1
(en)
|
2002-10-25 |
2005-04-07 |
Boehringer Ingelheim International Gmbh |
Macrocyclic peptides active against the hepatitis C virus
|
|
US20050159345A1
(en)
|
2002-10-29 |
2005-07-21 |
Boehringer Ingelheim International Gmbh |
Composition for the treatment of infection by Flaviviridae viruses
|
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
US7098231B2
(en)
|
2003-01-22 |
2006-08-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
CA2515216A1
(en)
|
2003-02-07 |
2004-08-26 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic hepatitis c serine protease inhibitors
|
|
DE602004029866D1
(de)
|
2003-03-05 |
2010-12-16 |
Boehringer Ingelheim Pharma |
Peptidanaloga mit inhibitorischer wirkung auf hepatitis c
|
|
WO2004101605A1
(en)
|
2003-03-05 |
2004-11-25 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibiting compounds
|
|
GB0307891D0
(en)
|
2003-04-04 |
2003-05-14 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
|
ES2320771T3
(es)
|
2003-04-16 |
2009-05-28 |
Bristol-Myers Squibb Company |
Inhibidores peptidicos de isoquinolina macrociclicos del virus de la hepatitis c.
|
|
CN1788006A
(zh)
|
2003-04-18 |
2006-06-14 |
安南塔制药公司 |
喹喔啉基大环丙型肝炎丝氨酸蛋白酶抑制剂
|
|
AU2004240704B9
(en)
|
2003-05-21 |
2009-10-22 |
Boehringer Ingelheim International Gmbh |
Hepatitis C inhibitor compounds
|
|
WO2004113365A2
(en)
|
2003-06-05 |
2004-12-29 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c serine protease tri-peptide inhibitors
|
|
US7125845B2
(en)
|
2003-07-03 |
2006-10-24 |
Enanta Pharmaceuticals, Inc. |
Aza-peptide macrocyclic hepatitis C serine protease inhibitors
|
|
CA2534649A1
(en)
|
2003-08-01 |
2005-02-10 |
Genelabs Technologies, Inc. |
Bicyclic imidazol derivatives against flaviviridae
|
|
WO2005014543A1
(ja)
|
2003-08-06 |
2005-02-17 |
Japan Tobacco Inc. |
縮合環化合物及びそのｈｃｖポリメラーゼ阻害剤としての利用
|
|
WO2005021584A2
(en)
|
2003-08-26 |
2005-03-10 |
Schering Corporation |
Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
|
|
US7112601B2
(en)
*
|
2003-09-11 |
2006-09-26 |
Bristol-Myers Squibb Company |
Cycloalkyl heterocycles for treating hepatitis C virus
|
|
RS20060197A
(sr)
|
2003-09-22 |
2008-09-29 |
Boehringer Ingelheim International Gmbh., |
Makrociklični peptidi koji su aktivni protiv hepatitisa c virusa
|
|
JP4525982B2
(ja)
|
2003-09-26 |
2010-08-18 |
シェーリング コーポレイション |
Ｃ型肝炎ウイルスのｎｓ３セリンプロテアーゼの大環状インヒビター
|
|
HRP20130098T1
(hr)
|
2003-10-14 |
2013-02-28 |
F. Hoffmann - La Roche Ag |
MAKROCIKLIÄŚKE KARBOKSILNE KISELINE I ACILSULFONAMIDNI SPOJEVI KAO INHIBITORI REPLIKACIJE HCV-a
|
|
US7132504B2
(en)
|
2003-11-12 |
2006-11-07 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
WO2005049622A1
(ja)
|
2003-11-19 |
2005-06-02 |
Japan Tobacco Inc. |
５－５員縮合複素環化合物及びそのｈｃｖポリメラーゼ阻害剤としての用途
|
|
JP2007532479A
(ja)
|
2003-11-20 |
2007-11-15 |
シェーリング コーポレイション |
Ｃ型肝炎ウイルスｎｓ３プロテアーゼの脱ペプチド化インヒビター
|
|
US7309708B2
(en)
|
2003-11-20 |
2007-12-18 |
Birstol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7135462B2
(en)
|
2003-11-20 |
2006-11-14 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
BRPI0416902A
(pt)
|
2003-12-11 |
2007-01-16 |
Schering Corp |
inibidores de ns3/ns4a serina protease do vìrus da hepatite c
|
|
EP1730167B1
(en)
|
2004-01-21 |
2011-01-12 |
Boehringer Ingelheim International GmbH |
Macrocyclic peptides active against the hepatitis c virus
|
|
HRP20130971T1
(hr)
|
2004-02-20 |
2013-11-08 |
Boehringer Ingelheim International Gmbh |
Inhibitori virusne polimeraze
|
|
DE602005015834D1
(de)
|
2004-02-27 |
2009-09-17 |
Schering Corp |
3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
|
|
WO2005087721A2
(en)
|
2004-02-27 |
2005-09-22 |
Schering Corporation |
Compounds as inhibitors of hepatitis c virus ns3 serine protease
|
|
EP1737881B1
(en)
|
2004-02-27 |
2009-06-24 |
Schering Corporation |
Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
|
|
AU2005219824B2
(en)
|
2004-02-27 |
2007-11-29 |
Merck Sharp & Dohme Corp. |
Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
|
|
CN103102389A
(zh)
|
2004-02-27 |
2013-05-15 |
默沙东公司 |
作为丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的硫化合物
|
|
EP1730165A1
(en)
|
2004-02-27 |
2006-12-13 |
Schering Corporation |
Inhibitors of hepatitis c virus ns3 protease
|
|
CN1946690A
(zh)
|
2004-02-27 |
2007-04-11 |
先灵公司 |
用作丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的含环丁烯二酮基团化合物
|
|
US20050249702A1
(en)
|
2004-05-06 |
2005-11-10 |
Schering Corporation |
(1R,2S,5S)-N-[(1S)-3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide as inhibitor of hepatitis C virus NS3/NS4a serine protease
|
|
DE602005015452D1
(de)
|
2004-05-20 |
2009-08-27 |
Schering Corp |
Substituierte proline als hemmer der ns3-serinprotease des hepatits-c-virus
|
|
WO2005121132A1
(ja)
|
2004-06-11 |
2005-12-22 |
Shionogi & Co., Ltd. |
抗ｈｃｖ作用を有する縮合ヘテロ環化合物
|
|
EP1763531A4
(en)
|
2004-06-28 |
2009-07-01 |
Boehringer Ingelheim Int |
ANALOGUE OF HEPATITIS-C INHIBITING PEPTIDES
|
|
PE20060569A1
(es)
|
2004-07-16 |
2006-06-22 |
Boehringer Ingelheim Int |
Compuestos de indol carbonilamino como inhibidores de la polimerasa ne5b del vhc
|
|
UY29016A1
(es)
|
2004-07-20 |
2006-02-24 |
Boehringer Ingelheim Int |
Analogos de dipeptidos inhibidores de la hepatitis c
|
|
JP4914355B2
(ja)
|
2004-07-20 |
2012-04-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃ型肝炎インヒビターペプチド類似体
|
|
US7816348B2
(en)
*
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|